Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

NervGen Pharma Corp.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

NervGen Pharma is a clinical-stage biotech company developing treatments for nerve damage and spinal cord injuries. The company focuses on therapies that promote nerve regeneration and repair using its proprietary platform, targeting conditions including traumatic spinal cord injury, multiple sclerosis, and peripheral nerve damage.